Front Line Medical Technologies Inc.

Front Line Medical Technologies Inc. specializes in two primary device categories: intravascular occluding balloon catheters designed for image-guided procedures, such as the COBRA-OS™, and single-use general-purpose syringes, like a 10 mL syringe. These devices are developed for specific clinical applications, including vascular interventions and fluid administration.

The company is headquartered in the United States. This location aligns with its regulatory compliance framework, particularly for devices authorized under FDA guidelines.

Devices from Front Line Medical Technologies Inc. are listed in the FDA’s Unique Device Identifier (UDI) database. This registry ensures traceability and transparency for authorized devices, including those classified under Class II.

The company’s devices, such as the COBRA-OS™ and 10 mL syringe, fall under Class II classification by the FDA. This classification typically applies to devices that pose moderate risk and require special controls beyond general controls to ensure safety and effectiveness.